Serum laminin and syndecan -1 : Novel biomarkers in predicting liver fibrosis stage in patients with hepatocllular carcinoma

Laminin and chromogranin A levels in viral hepatitis B

Laminin and chromogranin a levels in patients with liver cirrhosis

Evaluation of endoglin as a non–invasive marker of hepatic fibrosis in chronic hepatitis C patients

Biochemical markers of liver fibrosis in HCV patients

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Possible role of visfatin in development of liver fibrosis in metabolic syndrome with hepatic steatosis

Assessment of dendritic cells functions in HCV infected patients on hemodialysis

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Asymmetric dimethyl arginine in chronic active hepatitis